Sinphar Pharma 
Welcome,         Profile    Billing    Logout  
 3 Products   18 Diseases  3 Products   4 Trials   193 News 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
EndoTAG-1 (paclitaxel liposomal) / Sinphar Pharma
2018-000377-68: Treatment for Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas

Ongoing
3
218
Europe
Paclitaxel in cationic liposomes, EndoTAG-1, Powder and solvent for concentrate for solution for infusion
SynCore Biotechnology Co., Ltd., SynCore Biotechnology Co., Ltd.
Unresectable Locally Advanced/ Metastatic Adenocarcinoma of the Pancreas, Unresectable Locally Advanced/ Metastatic Adenocarcinoma of the Pancreas, Diseases [C] - Cancer [C04]
 
 
Veregen (sinecatechins) / Sinphar Pharma, Medigene
2018-001730-18: Phase III, random, one-site, pilot, open, parallell group trial for evaluating the eficacy and safety of electrocoagulation vs topic sinecatechins vs topic cidofovir in the High-grade anal intraepithelial neoplasia in HIV homosexuals males Ensayo clínico fase III, aleatorizado, unicéntrico, piloto, abierto, de grupos paralelos para valorar la eficacia y seguridad de la electrocoagulación vs sinecatequinas tópicas vs cidofovir tópico en el tratamiento de la neoplasia intraepitelial anal de alto grado, en varones que tienen sexo con hombres con infección por VIH (TreatAIN).

Not yet recruiting
3
108
Europe
Veregen, Cidofovir, Ointment, Cream, Veregen
Fundación Hospital Vall d'Hebron- Institut de Recerca, Instituto de Salud Carlos III
High-grade anal intraepithelial neoplasia Neoplasia intraepitelial anal de alto grado, High-grade anal intraepithelial neoplasia Neoplasia intraepitelial anal de alto grado, Diseases [C] - Virus Diseases [C02]
 
 
2013-003107-19: A trial to investigate the use of Veregen ointment in the treatment of vulval intraepithelial neoplasia, a severe skin disorder that may lead to vulval cancer.

Ongoing
2
56
Europe
Veregen 10% ointment, Veregen, Veregen
University of Birmingham, Sandwell and West Birmingham Hospitals NHS Trust, Medigene, NIHR RfPB
Vulval intraepithelial neoplasia (VIN)
 
 
NCT04597359: To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Recruiting
2
360
US, RoW
Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Sinecatechins, Camellia sinensis Leaf Catechins, Kunecatechins, Polyphenon E, Polyphenon E TM, Veregen
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Prostate Carcinoma
12/32
12/32
SB01 / Sinphar Pharma
NCT01151930: Long-Term Compassionate Use Study for Continued Administration of SCB01A-01

No Longer Available
N/A
NA
SCB01A
SynCore Biotechnology Co., Ltd.
Malignant Solid Tumour
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
EndoTAG-1 (paclitaxel liposomal) / Sinphar Pharma
2018-000377-68: Treatment for Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas

Ongoing
3
218
Europe
Paclitaxel in cationic liposomes, EndoTAG-1, Powder and solvent for concentrate for solution for infusion
SynCore Biotechnology Co., Ltd., SynCore Biotechnology Co., Ltd.
Unresectable Locally Advanced/ Metastatic Adenocarcinoma of the Pancreas, Unresectable Locally Advanced/ Metastatic Adenocarcinoma of the Pancreas, Diseases [C] - Cancer [C04]
 
 
Veregen (sinecatechins) / Sinphar Pharma, Medigene
2018-001730-18: Phase III, random, one-site, pilot, open, parallell group trial for evaluating the eficacy and safety of electrocoagulation vs topic sinecatechins vs topic cidofovir in the High-grade anal intraepithelial neoplasia in HIV homosexuals males Ensayo clínico fase III, aleatorizado, unicéntrico, piloto, abierto, de grupos paralelos para valorar la eficacia y seguridad de la electrocoagulación vs sinecatequinas tópicas vs cidofovir tópico en el tratamiento de la neoplasia intraepitelial anal de alto grado, en varones que tienen sexo con hombres con infección por VIH (TreatAIN).

Not yet recruiting
3
108
Europe
Veregen, Cidofovir, Ointment, Cream, Veregen
Fundación Hospital Vall d'Hebron- Institut de Recerca, Instituto de Salud Carlos III
High-grade anal intraepithelial neoplasia Neoplasia intraepitelial anal de alto grado, High-grade anal intraepithelial neoplasia Neoplasia intraepitelial anal de alto grado, Diseases [C] - Virus Diseases [C02]
 
 
2013-003107-19: A trial to investigate the use of Veregen ointment in the treatment of vulval intraepithelial neoplasia, a severe skin disorder that may lead to vulval cancer.

Ongoing
2
56
Europe
Veregen 10% ointment, Veregen, Veregen
University of Birmingham, Sandwell and West Birmingham Hospitals NHS Trust, Medigene, NIHR RfPB
Vulval intraepithelial neoplasia (VIN)
 
 
NCT04597359: To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Recruiting
2
360
US, RoW
Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Sinecatechins, Camellia sinensis Leaf Catechins, Kunecatechins, Polyphenon E, Polyphenon E TM, Veregen
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Prostate Carcinoma
12/32
12/32
SB01 / Sinphar Pharma
NCT01151930: Long-Term Compassionate Use Study for Continued Administration of SCB01A-01

No Longer Available
N/A
NA
SCB01A
SynCore Biotechnology Co., Ltd.
Malignant Solid Tumour
 
 

Download Options